Constellation Pharmaceuticals, Inc.
Therapeutic compounds and uses thereof
Last updated:
Abstract:
The present invention relates to compounds of formula (I) and formula (II): ##STR00001## and to salts thereof, wherein R.sup.1-R.sup.4 of formula (I) and R.sup.5-R.sup.6 of formula (II) have any of the values defined herein, and compositions and uses thereof. The compounds are useful as inhibitors of CBP and/or EP300. Also included are pharmaceutical compositions comprising a compound of formula (I) of formula (II), or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various CBP and/or EP300-mediated disorders.
Status:
Grant
Type:
Utility
Filling date:
21 Nov 2018
Issue date:
30 Jun 2020